Survival and Relapse Rate of Tuberculosis Patients Who Successfully Completed Treatment in Vietnam
Overview
Affiliations
Setting: Reported tuberculosis (TB) cure rates are high in Vietnam with the 8-month short-course chemotherapy regimen. However, long-term treatment outcomes are unknown.
Objective: To assess survival and relapse rates among patients successfully treated for new smear-positive pulmonary tuberculosis (PTB).
Methods: A cohort of patients treated in 32 randomly selected districts in northern Vietnam were followed up 12-24 months after reported cure or treatment success for survival and bacteriologically confirmed relapse. Measurements included sputum smear examination, culture and interview for recent treatment history.
Results: Of 304 patients included in the study, no information was available for 31 (10%) and 19 (6%) had died. Bacteriology results were available for 244 (80%). The median interval between treatment completion and follow-up was 19 months. Relapse was recorded in 21/244 (8.6%, 95%CI 5.4-13), including 9 (4%) with positive sputum smears, 3 (1%) with negative smears but positive culture and 9 (4%) who had started TB retreatment. Four of 12 culture-positive relapse cases (33%) had multidrug-resistant strains. If the definition of relapse was extended to include death, reportedly due to TB, the relapse proportion was 26/263 (9.9%, 95%CI 6.6-14).
Conclusion: A substantial proportion of patients (15%) had died or relapsed after being successfully treated for TB in northern Vietnam.
Multidrug-resistant tuberculosis.
Dheda K, Mirzayev F, Cirillo D, Udwadia Z, Dooley K, Chang K Nat Rev Dis Primers. 2024; 10(1):22.
PMID: 38523140 DOI: 10.1038/s41572-024-00504-2.
Mujtaba M, Richardson M, Shahzad H, Javed M, Raja G, Shaiq P J Trop Med. 2022; 2022:4408306.
PMID: 36478977 PMC: 9722313. DOI: 10.1155/2022/4408306.
Mathur N, Chatla C, Syed S, Patel Y, Pattnaik S, Mathai D Lung India. 2019; 36(6):519-524.
PMID: 31670300 PMC: 6852225. DOI: 10.4103/lungindia.lungindia_143_19.
Dangisso M, Markos Woldesemayat E, Datiko D, Lindtjorn B PLoS One. 2018; 13(3):e0193396.
PMID: 29529036 PMC: 5846790. DOI: 10.1371/journal.pone.0193396.
Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China.
Sun Y, Harley D, Vally H, Sleigh A PLoS One. 2017; 12(1):e0168865.
PMID: 28118372 PMC: 5261560. DOI: 10.1371/journal.pone.0168865.